Geen alternatieve tekst opgegeven voor deze afbeelding

Our colleagues Margarita KulakovaBart Heeg and Mahmoud Hashim collaborated on a large meta-review of the role of MRD negativity in long term survival outcomes in patients with multiple myeloma. The strong prognostic value of MRD negativity and its association with favorble outcomes sets the stage to adopt MRD as a treatment endpoint.

If you would like to know more about the value of MRD in MM, read the full text article for free at: